Entry Detail



General Information

Database ID:exR0081487
RNA Name:SLC25A6
RNA Type:mRNA
Chromosome:chrX
Starnd:-
Coordinate:
Start Site(bp):1386152End Site(bp):1392113
External Links:ENSG00000169100



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005943.1
chr19
1578339
1605445
-
AC018523.2
chr11
14493783
14520344
-
AHCY
chr20
34280268
34311802
-
ACBD3
chr1
226144679
226186741
-
AK2
chr1
33007940
33080996
-
AC087289.3
chr17
75898645
75930129
-
AL358113.1
chr9
69035747
69255187
+
ACTG1
chr17
81509971
81523847
-
ACLY
chr17
41866917
41930542
-
AC007192.1
chr19
18153158
18178117
+
AL022238.4
chr22
40346529
40410054
+
AC020915.5
chr19
58228914
58315183
+
ACOT7
chr1
6264269
6394391
-
AL133352.1
chr10
100505628
100529881
-
ADGRL2
chr1
81306160
81992436
+
ACTB
chr7
5527148
5563784
-
AC104109.3
chr5
134167170
134226071
-
AKIP1
chr11
8911139
8920084
+
AC245033.1
chr15
82536788
82573194
-
AC091167.2
chr15
90249556
90272208
+
ACVR2B
chr3
38453890
38493142
+
AKT2
chr19
40230317
40285536
-
AC026464.4
chr16
69299682
69322700
+
ALDH18A1
chr10
95605941
95656711
-
ADAR
chr1
154582057
154628013
-
AL109827.1
chr20
35632340
35674544
-
ADPRHL2
chr1
36088892
36093932
+
AC012651.1
chr15
42348103
42412317
+
AC138811.2
chr16
18788063
18801519
-
ACAD9
chr3
128879596
128916067
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-1182
chr1
231019841
231019863
-
hsa-miR-7847-3p
chr11
1880105
1880125
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005899.4
chr17
32328441
32329395
+
AC007773.1
chr19
32390050
32405560
-
AC007952.4
chr17
19112000
19112636
-
AC010331.1
chr19
47607873
47608454
-
AC016355.1
chr15
67541072
67542604
-
AC016876.2
chr17
7581964
7584086
-
AC017083.1
chr2
68252870
68253848
+
AC018521.1
chr17
47945424
47981736
+
AC020663.1
chr16
4730115
4752565
-
AC025181.2
chr5
32174471
32175272
+
AC026362.1
chr12
122975320
122982907
+
AC026803.2
chr19
48963975
48965158
+
AC114271.1
chr19
10333436
10336248
+
AC139149.1
chr17
81514047
81527776
+
AC140125.2
chr5
177782197
177794396
+
AC245014.3
chr1
145281116
145281462
+
AD000090.1
chr19
35557956
35581954
+
AL022311.1
chr22
37876148
37895563
+
AL117378.1
chr6
131901963
131920565
+
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA